Ihne-Schubert, Sandra Michaela http://orcid.org/0000-0001-8540-7122
Radovic, Teresa
Fries, Saskia
Frantz, Stefan
Einsele, Hermann
Störk, Stefan
Neuderth, Silke
Funding for this research was provided by:
interdisziplinäres zentrum für klinische forschung, universitätsklinikum würzburg (Z-2_CSP-08)
Universitätsklinikum Würzburg
Article History
Received: 24 June 2021
Accepted: 29 January 2024
First Online: 10 February 2024
Declarations
:
: The AmyKoS cohort and <sub>A</sub>MY-NEED<sub>S</sub> study protocol and procedures received positive votes from the Ethics Committee of the Medical Faculty of the University Würzburg (AmyKoS: vote 48/18; <sub>A</sub>MY-NEED<sub>S</sub>: vote 37/19)
: All participants provide written informed consent prior to any study examination.
: Not applicable.
: SMI-S received financial reimbursement for consulting, advisory board activities, speaker honoraries and/or travel support to attend scientific meetings by Akcea Therapeutics, Alnylam, Pfizer, Janssen-Cilag, and Takeda, and further research funding from Pfizer and Akcea Therapeutics. An internship was supported by ONLUS. She was fellow of the local Clinician Scientist program of the IZKF Würzburg. StF received consultancy and lecture fees as well as travel expenses from AMGEN Europe, AstraZeneca, Bayer Vital, Boehringer Ingelheim, Bristol-Meyers Squibb GmbH, Daiichi Sankyo, MSD, Novartis, Pfizer, Sanofi, Servier, Vifor. StS is supported by the CHFC Würzburg, and by the German Federal Ministry of Education and Research (BMBF). He has received consultancy and lecture fees as well as reimbursement of travel costs from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, and Servier. The other authors declare that they have no competing interests.